Search research articles
Contact Us
Filters
Showing results (321-330 of 357) with videos related to
Page
of 36
Sort By:
Molecular Pharmacology
|
January 1, 1981
Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes
M Nordqvist, D R Thakker, K P Vyas, et al.
Expert Opinion on Therapeutic Patents
|
March 30, 2010
Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers
Neeraj Mishra, Amit K Goyal, Shailja Tiwari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 21, 2000
The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs
R A Halpin, L A Geer, K E Zhang, et al.
Leukemia
|
December 7, 2007
Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML
H Hasle, J Abrahamsson, M Arola, et al.
Plos One
|
February 8, 2023
Agro-morphological and genetic variability analysis in oat germplasms with special emphasis on food and feed
Raj Kumar, Smriti Varghese, Deepanshu Jayaswal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1991
HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies
P F Smith, R S Eydelloth, S J Grossman, et al.
Human Molecular Genetics
|
February 5, 1999
Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3
K Kyo, M Parkes, Y Takei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1990
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase
S Vickers, C A Duncan, K P Vyas, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2000
Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists
B Lagu, D Tian, G Chiu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 23, 2003
Metabolism of rofecoxib in vitro using human liver subcellular fractions
Donald Slaughter, Norihiro Takenaga, Ping Lu, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 357) with videos related to
Sort By:
Page
of 36
Molecular Pharmacology
|
January 1, 1981
Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes
M Nordqvist, D R Thakker, K P Vyas, et al.
Expert Opinion on Therapeutic Patents
|
March 30, 2010
Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers
Neeraj Mishra, Amit K Goyal, Shailja Tiwari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 21, 2000
The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs
R A Halpin, L A Geer, K E Zhang, et al.
Leukemia
|
December 7, 2007
Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML
H Hasle, J Abrahamsson, M Arola, et al.
Plos One
|
February 8, 2023
Agro-morphological and genetic variability analysis in oat germplasms with special emphasis on food and feed
Raj Kumar, Smriti Varghese, Deepanshu Jayaswal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1991
HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies
P F Smith, R S Eydelloth, S J Grossman, et al.
Human Molecular Genetics
|
February 5, 1999
Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3
K Kyo, M Parkes, Y Takei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1990
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase
S Vickers, C A Duncan, K P Vyas, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2000
Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists
B Lagu, D Tian, G Chiu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 23, 2003
Metabolism of rofecoxib in vitro using human liver subcellular fractions
Donald Slaughter, Norihiro Takenaga, Ping Lu, et al.
Page
of 36